Search company, investor...

Predict your next investment

EQT Life Sciences company logo
Venture Capital
FINANCE | Investment Firms & Funds
lspvc.com

Investments

200

Portfolio Exits

50

Funds

13

Partners & Customers

2

Service Providers

1

About EQT Life Sciences

EQT Life Sciences is a venture capital firm specializing in early- to mid-stage life sciences companies. It was formerly known as Life Sciences Partners.

Headquarters Location

Johannes Vermeerplein 9

Amsterdam, 1071 DV,

Netherlands

31 20 664 5500

Want to inform investors similar to EQT Life Sciences about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest EQT Life Sciences News

Cardiac Dimensions

Jan 12, 2023

美国心脏疾病医疗器械研发商,完成3500万美元D轮融资,投资方为Horizon 3 Healthcare等领投,Arboretum Ventures、Hostplus、EQT Life Sciences、Lumira Ventures、M. H. Carnegie Co跟投。

EQT Life Sciences Investments

200 Investments

EQT Life Sciences has made 200 investments. Their latest investment was in Amolyt Pharma as part of their Series C on January 1, 2023.

CBI Logo

EQT Life Sciences Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/6/2023

Series C

Amolyt Pharma

$138.38M

No

7

1/5/2023

Series D

Cardiac Dimensions

$35M

No

8

8/23/2022

Series B - II

eTheRNA

$38.92M

No

6

6/13/2022

Series C

Subscribe to see more

$99M

Subscribe to see more

10

4/1/2022

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/6/2023

1/5/2023

8/23/2022

6/13/2022

4/1/2022

Round

Series C

Series D

Series B - II

Series C

Series B - II

Company

Amolyt Pharma

Cardiac Dimensions

eTheRNA

Subscribe to see more

Subscribe to see more

Amount

$138.38M

$35M

$38.92M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

8

6

10

10

EQT Life Sciences Portfolio Exits

50 Portfolio Exits

EQT Life Sciences has 50 portfolio exits. Their latest portfolio exit was New Amsterdam Pharma on November 22, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/22/2022

Reverse Merger

$99M

4

10/21/2021

IPO

$99M

Public

3

2/24/2021

Acquired

$99M

4

2/5/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

1/4/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/22/2022

10/21/2021

2/24/2021

2/5/2021

1/4/2021

Exit

Reverse Merger

IPO

Acquired

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

4

3

4

10

10

EQT Life Sciences Fund History

13 Fund Histories

EQT Life Sciences has 13 funds, including LSP 7.

Closing Date

Fund

Fund Type

Status

Amount

Sources

2/11/2022

LSP 7

$1,140M

2

3/10/2020

LSP 6

Multi-Stage Venture Capital

Closed

$600M

2

12/12/2017

LSP Health Economics Fund II

Late-Stage Venture Capital

Closed

$330M

2

6/2/2016

Life Sciences Partners V

Subscribe to see more

Subscribe to see more

$99M

10

3/10/2014

Health Economics Fund

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

2/11/2022

3/10/2020

12/12/2017

6/2/2016

3/10/2014

Fund

LSP 7

LSP 6

LSP Health Economics Fund II

Life Sciences Partners V

Health Economics Fund

Fund Type

Multi-Stage Venture Capital

Late-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Closed

Closed

Subscribe to see more

Subscribe to see more

Amount

$1,140M

$600M

$330M

$99M

$99M

Sources

2

2

2

10

10

EQT Life Sciences Partners & Customers

2 Partners and customers

EQT Life Sciences has 2 strategic partners and customers. EQT Life Sciences recently partnered with EQT Partners on November 11, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

11/10/2021

Partner

Sweden

LSP and EQT join forces in healthcare investing

The life science industry is going through a phase of unprecedented innovation and , through the partnership with LSP , EQT AB will be able to participate in this growth opportunity and open up doors for attractive new investments in the space . ''

1

11/24/2015

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

11/10/2021

11/24/2015

Type

Partner

Partner

Business Partner

Country

Sweden

United States

News Snippet

LSP and EQT join forces in healthcare investing

The life science industry is going through a phase of unprecedented innovation and , through the partnership with LSP , EQT AB will be able to participate in this growth opportunity and open up doors for attractive new investments in the space . ''

Subscribe to see more

Subscribe to see more

Sources

1

10

EQT Life Sciences Service Providers

1 Service Provider

EQT Life Sciences has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Series A

Counsel

General Counsel

Service Provider

Associated Rounds

Series A

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

EQT Life Sciences Team

18 Team Members

EQT Life Sciences has 18 team members, including current Founder, Owner, Martijn Keijwegt.

Name

Work History

Title

Status

Martijn Keijwegt

Founder, Owner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Martijn Keijwegt

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder, Owner

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.